crisprtx
Health Care · Cell & Gene Therapy

crisprtx revenue, results and funding

crisprtx filed revenue of $3.5M for 2025.

Data updated Nov 19, 2026 · Back to the company report
$3.5MRevenue, 2025
−$581.6MNet income, 2025

Results by year

YearRevenueNet incomeTotal assetsLANG_CR_S_M_TAX_PAIDLANG_CR_S_M_TAX_EXPENSELANG_CR_S_M_BUYBACKSLANG_CR_S_M_CAPEXLANG_CR_S_M_SBCLANG_CR_S_M_RNDLANG_CR_S_M_OPERATING_INCOMELANG_CR_S_M_CASH
2025$3.5M−$581.6M$2.3B$3M$3.6M–$914k$72.5M$284.8M−$664.6M$347.6M
2024$37.3M−$366.3M$2.2B–$3.6M–$1.9M$86.6M$310.2M−$466.6M$298.3M
2023$371.2M−$153.6M$2.2B–$2.9M–$9.5M$81M$387.3M−$222.5M$389.5M
2022$1.2M−$650.2M$2.2B–−$325k–$37.2M$97.9M$461.6M−$673.2M$211.9M
2021$915M$377.7M$2.8B–$1.9M–$81.7M$102.4M$340.6M$373.5M$923M
2020$719k−$348.9M$1.8B–$809k–$18.4M$66M$221.4M−$354.4M$1.2B
2019$289.6M$66.9M$1.1B–$448k–$6.7M$44.1M$179.4M$46.7M$943.8M
2018$3.1M−$165M$489M–$553k$57k$2.8M$35M$113.8M−$158.9M$456.6M
2017$41M−$68.4M$271.3M–$1.7M–$7.8M$18.9M$69.8M−$64.6M$239.8M
2016$5.2M−$23.2M$345M–$484k–$3M$10.8M$42.2M−$68.1M$315.5M
2015$247k−$25.5M$159.4M–$7k–$1.2M$3.7M$12.6M−$25.7M$156M
2014–−$7M––−$63k––$695k$1.5M−$6.6M$945k
2013––––––––––$361k
Sources: SEC

How to cite

crisprtx, Financials. Alion, Nov 19, 2026. https://alion.io/company/crisprtx/financials

.json · .md · CC BY-SA 4.0